ProShare Advisors
TIL icon

ProShare Advisors’s Instil Bio TIL Stock Holding History

ProShare Advisors’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-859
Closed -$11.4K – 1905
2023
Q1 		$11.4K Sell
859
-125
-13% -$1.85K ﹤0.01% 1762
2022
Q4 		$12.4K Buy
984
+55
+6% +$2.72K ﹤0.01% 1825
2022
Q3 		$90K Buy
929
+35
+4% +$4K ﹤0.01% 1582
2022
Q2 		$83K Sell
894
-280
-24% -$39.7K ﹤0.01% 1640
2022
Q1 		$251K Sell
1,174
-325
-22% -$76K ﹤0.01% 1757
2021
Q4 		$514K Buy
+1,499
New +$579K ﹤0.01% 1420

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ProShare Advisors's TIL Position: Q2 2023 in Review

ProShare Advisors sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 859 shares — an estimated $11.4K sold.

ProShare Advisors first reported a position in TIL in Q4 2021 and held it in 6 quarters. The position peaked at $514K in Q4 2021. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

  • ProShare Advisors reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
  • ProShare Advisors sold 859 Instil Bio shares in Q2 2023, an estimated $11.4K.
  • ProShare Advisors first reported a position in Instil Bio in Q4 2021 and held it in 6 quarters.
  • ProShare Advisors's Instil Bio position peaked at $514K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.